Shai Shen-Orr

Shai Shen-Orr is the co-founder and chief scientist at CytoReason, known for his expertise in computational disease models. In a captivating discussion, he explains how CytoReason turns vast biological data into actionable insights, revolutionizing drug development. Shai emphasizes the importance of disease modeling in predicting treatment effects and guiding clinical trials. He also shares his vision for the future, where AI automates routine tasks, allowing researchers to focus on groundbreaking discoveries in healthcare.

Shai Shen-Orr, Co-founder and Chief Scientist at Cytoreason, shares his insights on using AI in drug development. He discusses how computational disease models help transform vast biological data into actionable insights. Shai explains the importance of automating routine tasks to enable scientists to focus on critical issues and ensure data trustworthiness. The conversation also dives into how CytoReason assists major pharma players like Pfizer in making informed treatment decisions while addressing the challenges of an ever-expanding data landscape.